About the NEI ORM
The NEI Office of Regenerative Medicine (ORM) provides scientific and administrative support to the vision research community. The ORM facilitates collaboration among scientists across the NIH and other federal agencies, academia, and nonprofit and private research sectors. ORM’s goal is to accelerate progress in regenerative medicine for vision.
Events and Announcements
ARVO 2021 Special Session - NEI Audacious Goals Initiative (AGI) presents:
New factors in regenerative medicine for vision research. This session is now available for viewing.
Tvst Regenerative Medicine Special Edition released - The NEI Audacious Goals Initiative: Advancing the Frontier of Regenerative Medicine
October 1, 2021: 3-D ROC mandatory registration deadline
Solvers must register their intent to participate in the final phase of the 3-D Retinal Organoid Challenge.
October 27, 2021 from 1:00 -2:00p EST: Vision Innovation Seminar
Dr. Bo Chen will present on his recent work - view more details here
NEI Vision Innovation Seminars (VIS)
NEI has launched a webinar series to help promote and disseminate cutting-edge research that is relevant to the vision community. Authors of recently published articles will present their work to the research community through this monthly webinar series.
NEI Audacious Goals Initiative (AGI)
NEI is pushing the boundaries of vision science. By facilitating cross-disciplinary research, the AGI is advancing regenerative medicine to tackle the most devastating and difficult-to-treat eye diseases.
NEI 3-D Retina Organoid Challenge (3-D ROC)
3-D ROC is spurring development of robust systems for modeling retinal diseases and testing new regenerative therapies.
NEI AMD Integrative Biology Initiative
NEI is taking the first important steps to correlate phenotypes, genotypes, and imaging information in the newly created AMD Integrative Biology Initiative.
NIH Regenerative Medicine Innovation Project (RMIP)
This trans-NIH effort was established by the 21st Century Cures Act to accelerate progress in the field by supporting clinical research on adult stem cells, while promoting scientific rigor and protecting patient safety.
ORM Contacts
|
|
|
|
Tom Greenwell, Ph.D. |
Amber Reed |
